drugset / Trial / NCT03962725
Avoiding Neuromuscular Blockers to Reduce Complications
RandomizedParallel-groupDouble-blindTreatment
Summary
The goal of this study to evaluate whether eliminating the use of non-depolarizing neuromuscular blocking agents (NMBA) for maintenance of general anesthesia reduces postoperative pulmonary complications in higher risk patients.
Timeline
- Start
- 2019-08-07
- Primary completion
- 2022-12-19
- Completion
- 2022-12-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rocuronium | Other / unclassified | 0.6 mg/kg | — |
| Comparator | Rocuronium | Other / unclassified | 1 mg/kg | — |
| Background | Dexmedetomidine | Other / unclassified | — | — |
| Background | Ketamine | Small molecule | — | — |
| Background | Propofol | Small molecule | — | — |